Healthcare & Life Sciences
Orpheris
United States
acquired
acquired
Stage
About
Orpheris was a United States–based biopharmaceutical company focused on developing therapeutic drugs. Catalio Capital lists Orpheris as a portfolio company that exited in 2021.
Explore Orpheris's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.